Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides

计划入组 15 人 · 首次发布于 2022 年 9 月 2 日

Evaluation of IL-17, TNF-alpha, RANKL Levels in Gingival Cervicular Fluid

计划入组 40 人 · 首次发布于 2022 年 2 月 10 日

Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.

计划入组 310 人 · 首次发布于 2007 年 7 月 17 日

LCB-36

YQ-36

YFJ-36

Simcha Il 18, Inc.

United States

Alpha Metallurgical

United States

Zeno Alpha, Inc.

United States

Turn Therapeutics Initiates First Clinical Trial of Topical IL-36 Inhibitor GX-03 for Moderate-to-Severe Eczema

Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03

Roswell Park Researchers Develop IL-36 Gamma 'Armored' CAR T Cells to Eradicate Solid Tumors